Anavex Life Sciences Corp (AVXL)
3.67
-0.13
(-3.42%)
USD |
NASDAQ |
Apr 19, 13:45
Anavex Life Sciences Price: 3.67 for April 19, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 18, 2024 | 4.05 | 4.08 | 3.79 | 3.80 | 1.653M |
| Apr 17, 2024 | 4.20 | 4.200 | 4.02 | 4.07 | 1.337M |
| Apr 16, 2024 | 4.15 | 4.19 | 4.06 | 4.12 | 1.252M |
| Apr 15, 2024 | 4.31 | 4.364 | 4.175 | 4.23 | 1.090M |
| Apr 12, 2024 | 4.41 | 4.466 | 4.16 | 4.295 | 1.128M |
| Apr 11, 2024 | 4.30 | 4.50 | 4.30 | 4.45 | 803845.0 |
| Apr 10, 2024 | 4.23 | 4.295 | 4.17 | 4.29 | 1.412M |
| Apr 09, 2024 | 4.40 | 4.445 | 4.29 | 4.39 | 975661.0 |
| Apr 08, 2024 | 4.45 | 4.51 | 4.34 | 4.39 | 862071.0 |
| Apr 05, 2024 | 4.45 | 4.52 | 4.34 | 4.42 | 1.116M |
| Apr 04, 2024 | 4.69 | 4.702 | 4.46 | 4.48 | 1.525M |
| Apr 03, 2024 | 4.52 | 4.76 | 4.455 | 4.62 | 1.077M |
| Apr 02, 2024 | 4.85 | 4.865 | 4.515 | 4.54 | 1.470M |
| Apr 01, 2024 | 5.08 | 5.08 | 4.875 | 5.02 | 819546.0 |
| Mar 28, 2024 | 5.01 | 5.20 | 4.981 | 5.09 | 978032.0 |
| Mar 27, 2024 | 4.91 | 5.11 | 4.80 | 5.06 | 932846.0 |
| Mar 26, 2024 | 4.66 | 5.03 | 4.615 | 4.84 | 1.344M |
| Mar 25, 2024 | 4.66 | 4.71 | 4.48 | 4.55 | 1.355M |
| Mar 22, 2024 | 5.05 | 5.08 | 4.63 | 4.66 | 1.299M |
| Mar 21, 2024 | 5.19 | 5.29 | 5.10 | 5.11 | 1.097M |
| Mar 20, 2024 | 4.85 | 5.12 | 4.82 | 5.12 | 988668.0 |
| Mar 19, 2024 | 4.85 | 4.920 | 4.80 | 4.84 | 1.530M |
| Mar 18, 2024 | 5.11 | 5.15 | 4.81 | 4.82 | 1.534M |
| Mar 15, 2024 | 5.09 | 5.28 | 5.08 | 5.11 | 6.457M |
| Mar 14, 2024 | 5.34 | 5.36 | 5.09 | 5.14 | 1.249M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.22
Minimum
Aug 05 2019
28.86
Maximum
Jun 28 2021
8.622
Average
8.02
Median
Jul 25 2023
Price Benchmarks
| Ventyx Biosciences Inc | 4.38 |
| Vertex Pharmaceuticals Inc | 394.39 |
| Sarepta Therapeutics Inc | 115.00 |
| Checkpoint Therapeutics Inc | 1.50 |
| NovaBay Pharmaceuticals Inc | 0.0812 |
Price Related Metrics
| Price to Book Value | 2.223 |
| Earnings Yield | -14.99% |
| Market Cap | 301.35M |